SEC Form 4 · accession 0001127602-16-043508
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 24, 2016
Accepted (ET)
Feb 26, 2016 · 12:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 24, 2016 | M | 24,388 | $36.25 | A | 402,707 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $69.99 | D | 402,607 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.03 | D | 402,507 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.04 | D | 402,407 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $70.05 | D | 402,207 | D | |
| Common Stock | Feb 24, 2016 | S | 164 | $70.08 | D | 402,043 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.155 | D | 401,943 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.16 | D | 401,843 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.24 | D | 401,743 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.265 | D | 401,643 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $70.29 | D | 401,443 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.315 | D | 401,343 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $70.43 | D | 401,143 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.46 | D | 401,043 | D | |
| Common Stock | Feb 24, 2016 | S | 300 | $70.48 | D | 400,743 | D | |
| Common Stock | Feb 24, 2016 | S | 400 | $70.50 | D | 400,343 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.505 | D | 400,243 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.52 | D | 400,143 | D | |
| Common Stock | Feb 24, 2016 | S | 400 | $70.54 | D | 399,743 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.545 | D | 399,643 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.55 | D | 399,543 | D | |
| Common Stock | Feb 24, 2016 | S | 9 | $70.56 | D | 399,534 | D | |
| Common Stock | Feb 24, 2016 | S | 300 | $70.59 | D | 399,234 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $70.595 | D | 399,034 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.62 | D | 398,934 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $70.66 | D | 398,834 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $36.25 | Feb 24, 2016 | M | 24,388 | D | Feb 24, 2013 | Feb 24, 2019 | Common Stock | 24,388 | 0 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.